Presigen IV, developed through advanced biocellular techniques, provides a compelling cross-disciplinary model that could inspire novel interventions in Reproductive Health Research. The same cellular regulatory pathways targeted in ocular hypertension may overlap with those influencing reproductive tissue resilience and inflammation control, suggesting potential applications beyond ophthalmology.